• The SYNTAX score was developed to grade the anatomical complexity of coronary lesions in patients with LM or 3-vessel disease, and was found to be an independent predictor of long-term MACCE in patients treated with PCI but not CABG.
Guide to Calculate the SYNTAX Score
• The SYNTAX score was developed to grade the anatomical complexity of coronary lesions in patients with LM or 3-vessel disease, and was found to be an independent predictor of long-term MACCE in patients treated with PCI but not CABG.
• The SYNTAX II score is a combination of anatomical and clinical factors [age, creatinine clearance, LV function, gender, COPD, and PVD] and predicts long-term mortality in patients with 3-vessel or LM disease. It was found to be superior to SYNTAX score in guiding decisionmaking between CABG and PCI in SYNTAX trial.
Timing of Revascularization (PCI or CABG)
• For patients with severe symptoms (CCS III-IV) and for those with high-risk anatomy (LM disease or equivalent, 3-vessel disease or proximal LAD or depressed ventricular function), revascularization should be performed within 2 weeks.
• For all other patients with SCAD, revascularization should be performed within 6 weeks. 
Indications for

Recommendations for Revascularization in Patients with Diabetes
Recommendations for Antithrombotic Treatment in SCAD patients undergoing PCI
• Several randomized trials compared short duration (3-6 months) of DAPT after new-generation DES against extended duration (12-24 months) and consistently showed a lack of benefit in terms of ischaemic outcome but a higher risk of bleeding. 
Recommendations for Antithrombotic
Procedural Aspects of CABG
• Data from non-randomized studies reveal unequivocally that the use of bilateral IMA is associated with improved long-term survival, as well as fewer MI and need for re-operation.
• Bilateral IMA grafting should be considered in patients <70 years of age.
Procedural Aspects of PCI
New-Generation DES
• New-generation DES, with thin strut stent platforms, biocompatible durable or biodegradable polymers and limus-based antiproliferative agents, have further advanced efficacy and safety compared with early-generation DES and BMS.
• Compared with early-generation DES, repeat revascularization was reduced by 10-20%.
• Compared with BMS and early-generation DES, new-generation DES has also improved safety outcomes including death, MI and stent thrombosis.
• Several studies have reported an approximately 50% lower risk of stent thrombosis, than with early-generation DES, particularly during the late phase, and some studies reported a lower risk of stent thrombosis than with BMS.
• New-generation DES should therefore be considered by default in all clinical conditions and lesion subsets.
• Among patients who require anticoagulation with NOACs, undergo non-cardiac surgery, experience bleeding complications, or are non-compliant with medication intake, previous concerns relating to differences in the duration of DAPT and risks associated with DAPT cessation are not substantiated in recent data sets
Revascularization in STEMI Recommendations for Revascularization in NSTE-ACS
• Urgent coronary angiography (<2 hours) is recommended in patients at very high risk (refractory angina, with associated HF, cardiogenic shock, life-threatening ventricular arrhythmias, or haemodynamic instability).
• An early invasive strategy (<24 hours) is recommended in patients with at least one primary high-risk criterion (Relevant rise in troponin, Dynamic ST-or T-wave changes).
• An invasive strategy (<72 hours after presentation) is indicated In lower-risk subsets but with at least one secondary high-risk criterion (DM, EF <40%, Post-infarction angina, Recent PCI, Prior CABG) or recurrent symptoms. 
Recommendations for Management of
Recommendations for Combined Valvular and Coronary Interventions
• Observational data from the STICH trial suggest that adding mitral valve repair to CABG in patients with LVEF ≤35% and moderate-to-severe mitral regurgitation offers better survival than CABG alone.
Recommendations for Treatment of Arrhythmias after Revascularization
